Targeting Myocardial Metabolism for the Treatment of Stable Angina

E-ISSN： 1873-4286|19|9|1587-1592

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1587-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is there a Role for Antioxidants in the Treatment of Stable Angina?

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1601-1615

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Angina Pectoris: Current Medical Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1569-1580

Bentham Science Publishers

Access to resources Recommend Favorite

Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 1, 2007-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Trimetazidine Modified Release in the Treatment of Stable Angina: TRIUMPH Study1

By Vladimir I. Makolkin Konstantin K. Osadchiy

Clinical Drug Investigation, Vol. 24, Iss. 12, 2004-01 ,pp. : 731-738

Adis International

Access to resources Recommend Favorite

Novel Anti-platelet Agents for the Treatment of Stable Angina Pectoris

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1581-1586

Bentham Science Publishers

Access to resources Recommend Favorite